Page last updated: 2024-08-23

epirubicin and Mucositis, Oral

epirubicin has been researched along with Mucositis, Oral in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19903 (30.00)18.7374
1990's3 (30.00)18.2507
2000's1 (10.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, M; Bamba, N; Enami, A; Makihara, K; Masaoka, M; Masuda, N; Mizutani, M; Shikata, A; Takada, S; Yamamoto, M; Yamamura, J; Yasojima, H1
Fukazawa, M; Kashiwaba, K; Kawaguchi, H; Koga, C; Mori, E; Nakamura, Y; Nishimura, S; Ohno, S; Satou, S; Sawamura, K; Shigematsu, H1
Campanella, G; Clemente, C; D'Attoma, B; Giotta, F; Linsalata, M; Orlando, A; Riezzo, G; Russo, F1
Bonadonna, G; Bonfante, V; Villani, F1
Basser, RL; Cebon, J; Duggan, G; Green, MD; Mihaly, G; Rosenthal, MA; Sobol, MM1
de Vries, EG; Mulder, NH; Sluiter, WJ; Spijkervet, FL; Timens, W; Timmer-Bosscha, H; van der Graaf, WT; Wymenga, AN1
Davis, JA; Kaye, SB; O'Neill, VJ; Paul, J; Reed, NS; Vasey, PA1
Kobayashi, T; Kozuru, M; Masaoka, T; Oguro, M; Sampi, K; Shibata, H; Shirai, T; Shirakawa, S; Sugiyama, H; Umeda, M1
Boyd, MA; Case, DC; Ervin, TJ; Gams, R; Oldham, FB1

Trials

5 trial(s) available for epirubicin and Mucositis, Oral

ArticleYear
The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study.
    BMC cancer, 2013, Feb-04, Volume: 13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cholera Toxin; Cyclophosphamide; Diarrhea; Enzyme-Linked Immunosorbent Assay; Epidermal Growth Factor; Epirubicin; Female; Fluorouracil; Ghrelin; Glucagon-Like Peptide 2; Haptoglobins; Humans; Intestinal Absorption; Intestinal Mucosa; Italy; Lactulose; Mannitol; Middle Aged; Peptides; Permeability; Prospective Studies; Protein Precursors; Stomatitis; Time Factors; Treatment Outcome

2013
Comparative study of the pharmacokinetics and toxicity of high-dose epirubicin with or without dexrazoxane in patients with advanced malignancy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:8

    Topics: Adult; Aged; Drug Administration Schedule; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasms; Razoxane; Stomatitis; Vomiting

1994
Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression
    International journal of radiation oncology, biology, physics, 1996, Jun-01, Volume: 35, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Epirubicin; Female; Humans; Male; Mouth Mucosa; Nasopharyngeal Neoplasms; Neoplasm Staging; Stomatitis; Treatment Outcome

1996
A new in vitro assay for quantitation of chemotherapy-induced mucositis.
    British journal of cancer, 1997, Volume: 76, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Epithelium; Female; Fluorouracil; Humans; Male; Microscopy, Fluorescence; Middle Aged; Mouth Mucosa; Staining and Labeling; Stomatitis; Thiotepa

1997
A dose-finding study of carboplatin-epirubicin-docetaxel in advanced epithelial ovarian cancer.
    British journal of cancer, 2002, May-06, Volume: 86, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Diarrhea; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Stomatitis; Taxoids

2002

Other Studies

5 other study(ies) available for epirubicin and Mucositis, Oral

ArticleYear
[Therapeutic effect of rebamipide for oral mucositis associated with FEC therapy for breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:11

    Topics: Adult; Aged; Alanine; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Quinolones; Stomatitis

2014
[High incidence-rate of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy (FEC100)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:3

    Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Mouthwashes; Steroids; Stomatitis

2012
Toxic and therapeutic activity of 4'-epi-doxorubicin.
    Tumori, 1982, Apr-30, Volume: 68, Issue:2

    Topics: Adolescent; Adult; Aged; Alopecia; Arrhythmias, Cardiac; Bone Marrow Diseases; Doxorubicin; Drug Evaluation; Epirubicin; Female; Heart; Humans; Male; Middle Aged; Neoplasms; Stereoisomerism; Stomatitis; Vomiting

1982
[A phase II study of epirubicin in acute leukemia: a cooperative group study].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:8

    Topics: Acute Disease; Adult; Aged; Anorexia; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Humans; Leukemia; Male; Middle Aged; Nausea; Stomatitis

1986
Phase I-II trial of high-dose epirubicin in patients with lymphoma.
    Cancer research, 1987, Dec-01, Volume: 47, Issue:23

    Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Bone Marrow; Doxorubicin; Drug Evaluation; Epirubicin; Fever; Humans; Lymphoma; Middle Aged; Nausea; Stomatitis; Vomiting

1987